Delivery Order SPE2DB22D1106-SPE2DB24FFEB6

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,003.40 firm fixed-price delivery order contract is for the supply of 45 gram tubes of 0.1% Tretinoin cream. The contract has an ultimate completion date of August 7, 2024 and was awarded on August 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tretinoin 0.01% Gel in 15 gram quantities. The award, valued at $1,322.40, is a firm fixed-price contract with a completion date of September 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award with ID SPE2DB20D6035 and SPE2DB24FD1KH was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,861.43 firm fixed-price delivery order is for the supply of 45 gram tubes of 0.05% Tretinoin gel, which is a topical medication used to treat certain skin conditions. The contract has an ultimate completion date of December 21, 2023. This award is part of a larger...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Tretinoin 0.05% Gel in 45 gram quantities, with a total ceiling value of $6,272.87. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of June 10, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,597.60, is for the delivery of 45-gram tubes of 0.05% Tretinoin cream. The contract has an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in SAM.gov since 2002 and has a substantial Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency awarded a delivery order valued at approximately $775 to Amerisourcebergen Drug Corporation for the supply of 45-gram tubes of 0.01% tretinoin gel. The contract has a firm fixed price and calls for delivery to a facility in Conshohocken, Pennsylvania between July 21-24, 2023. As a prime medical supply contractor supporting the Department of Defense, Amerisourcebergen will fulfill this requirement for a topical acne medication to treat active-duty military and their...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order valued at approximately $742 to Amerisourcebergen Drug Corporation for the supply of 45-gram tubes of 0.025% tretinoin gel. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 15 through September 18, 2023. This delivery order was issued against an existing DLA medical supply vehicle and provides a needed...
This federal contract award, with an ID of SPE2DB20D3505|SPE2DB22FU2G4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,041.47 firm fixed-price delivery order is for the supply of 45 gram tubes of 0.05% Tretinoin cream. The contract has an ultimate completion date of August 26, 2022 and was awarded on August 25, 2022. This order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tretinoin 0.05% gel 45 gm. The contract has a ceiling value of $3,336.84 and is structured as a Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 45 gram tubes of 0.05% Tretinoin cream, a topical retinoid used to treat certain skin conditions. The contract is a firm-fixed price delivery order with a ceiling value of $2,014.38 and a period of performance through May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFEB6
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $2,443.32 contract is for the supply of 45-gram tubes of 0.05% Tretinoin gel, a topical retinoid medication. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 held by Amerisourcebergen to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is scheduled for completion by July 26, 2024.

Generated 10/27/24, 2:55 AM